WELCOME TO Cadila Pharmaceuticals Sweden

Cadila Pharmaceuticals Sweden AB, located at Karolinska Institutet Science Park, Solna is a wholly-owned subsidiary of Cadila Pharmaceuticals Limited, India.

The Swedish office is established to initiate and manage ongoing and future collaborations between European companies and institutions and Cadila group companies. With a highly flexible business model, we wish to work together with companies, venture capitalists and universities with research, development, manufacturing and commercial collaborations.

As a pharmaceutical company we operate fully integrated development facilities, ranging from CMC, pre-clinical and clinical studies, as well as commercial manufacturing with the efficiency, quality and result focus expected from a major pharma company.

Cadila Pharmaceuticals Limited, established in 1951 is one of the largest privately held pharmaceutical companies in India. We are developing, manufacturing, distributing and marketing pharmaceutical products across multiple therapeutic areas Read More


Formulation development
Compliant with international GLP guidelines


In-house ward, unique access through hospital ownership and extensive investigator network
USFDA and EMA compliant studies performed according to ICH-GCP


GMP status to meet needs of all major markets globally Wide range of formulations and APIs produced for own and others’ markets


More than 400 brands across 19 therapeutic areas
More than 800 SKUs, 9,500 person work force, covering 250,000 physicians in India